Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?
Unit of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy. Electronic address: umbertocapitanio@gmail.com.
Umberto
U
Capitanio
Unit of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Alessandro
A
Larcher
Unit of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Paolo
P
Dell'Oglio
Unit of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, San Raffaele Scientific Institute, Milan, Italy.
Francesco
F
Montorsi
D002292:Carcinoma, Renal Cell; D006801:Humans; D007680:Kidney Neoplasms; D016609:Neoplasms, Second Primary; D011446:Prospective Studies